Urogynecologist Judy Yeh, MD, FACOG and the Tift Regional Medical Center operating room team conducted the first Altaviva ...
MedPage Today on MSN
FDA Flags Medtronic Recall as Most Serious; Hep B Cure? Appendectomy for UC
The FDA designated the recall of certain Medtronic Bravo esophageal pH monitoring capsules as class I, the most serious type.
The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.
An update from the phase 2 LEGEND trial shows that the investigational nonviral gene therapy detalimogene voraplasmid has achieved a 62% complete response rate at six months in patients with high-risk ...
For individuals facing fear, uncertainty and repeated procedures associated with recurrent low-grade intermediate-risk bladder tumors, timely access to treatment can be critical. ZUSDURI, the first ...
A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback